Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).

Welcome to the era of "biological teleportation"

http://www.quickmeme.com/meme/3rjdr3/
"Craig Venter has built a prototype of a “Digital Biological Converter” (DBC) that would allow what he calls “biological teleportation”: receiving DNA sequences over the Internet to synthesize proteins, viruses and even living cells, The Guardian reports."

Jean-Michel Billaut, a digital economist: "Hébé ... Cela va loin ... Balader des bouts d'ADN sur le net , imprimer des cellules humaines ou des médicaments ..."
Publié par le
Libellés : , , , ,

Aucun commentaire:

Enregistrer un commentaire

Inscription à : Publier les commentaires (Atom)